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E-mail addresses: linjian@pku.edu.cn (J. Lin), binxiH-REV107 is a Ca2+-independent phospholipase A1/2, and it is also a pro-apoptosis protein belonging
to the novel class II tumor suppressor family, H-REV107-like family. Here we report the solution
structure of the N-terminal catalytic domain of human H-REV107, which has a similar architecture
to classical NlpC/P60 domains, even though their fold topologies are different due to circular permu-
tation in the primary sequence. The phospholipase active site possesses a structurally conserved
Cys–His–His catalytic triad as found in NlpC/P60 peptidases, indicating H-REV107 should adopt a
similar catalytic mechanism towards phospholipid substrates to that of NlpC/P60 peptidases
towards peptides. As H-REV107 is highly similar to lecithin retinol acyltransferase, our study also
provides structural insight to this essential enzyme in retinol metabolism.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
H-REV107 (also known as H-REV107-1, H-REV107-3 and
HRSL3) is a representative of a novel class II tumor suppressor fam-
ily, designated as H-REV107-like family [1]. The H-REV107 gene is
ubiquitously expressed in most normal tissues, but obviously
downregulated in many kinds of tumor cells like carcinoma of
ovary, cervix, and kidney etc. [2,3]. Overexpression of H-REV107-
like proteins efﬁciently inhibits the growth of tumor cells and in-
duces apoptosis [4–7].
H-REV107-like proteins were found to be homologous to leci-
thin retinol acyltransferase (LRAT), an enzyme that catalyzes the
transfer of the sn-1 acyl group of phosphatidylcholine (PC) to all-
trans-retinol and forming a retinyl ester [8,9]. Recently, it was
demonstrated that H-REV107 and other members of H-REV107-
like family, TIG3 and HRASLS2, possess Ca2+-independent phospho-
lipase A1/2 activity towards a variety of phospholipid substrates
in vivo and in vitro, indicating their involvement in phospholipid
metabolism in cells [10–13].chemical Societies. Published by E
tic Resonance Center, Peking
tic Resonance Center, Peking
a@pku.edu.cn (B. Xia).Based on primary sequence analysis, it was proposed that LRAT
family proteins, including H-REV107, show a circular permutation
with respect to classical members of NlpC/P60 superfamily, which
mostly comprises prokaryotic peptidases [14]. H-REV107 contains
a conserved proline-rich motif at the N terminus and a putative C-
terminal transmembrane domain which was found to be crucial for
cellular localization, but not necessary for the enzyme activity
[4,12].
Here we report the solution structure of the catalytic N-termi-
nal domain of H-REV107 (H-REV107N) without the putative C-ter-
minal transmembrane domain, the ﬁrst structure of the LRAT
family, which provides structural insight for the enzyme activities.
2. Materials and methods
2.1. Sample preparation
The plasmid construction, protein expression and puriﬁcation,
and NMR sample preparation were described previously [15].
2.2. NMR spectroscopy
The backbone sequential and side-chain assignments of H-
REV107N were reported previously [15]. The three-dimensional
15N-edited, 13C-edited aliphatic and 13C-edited aromatic NOESY-
HSQC spectra (mixing time 100 ms) were collected on Brukerlsevier B.V. All rights reserved.
Table 1
Restraints and structural statistics.
Restraints
Intra-residue distance restraints 1317
Sequential distance restraints 655
Medium range distance restraints 315
Long range distance restraints 542
Total unambiguous distance restraints 2832
Total ambiguous distance restraints 654
Hydrogen bond restraints 26
Dihedral angle restraints (u and w) 74
Restraints violations
Distance (>0.3 Å) 0
Dihedral angle (>5) 0
AMBER energy (kcal/mol)
Mean AMBER energy 6192.14 ± 14.00
NOE distance restraints violation energy 21.44 ± 2.57
Torsion angle restraints violation energy 1.00 ± 0.24
RMSD from mean structure (Å)
Backbone heavy atoms in secondary structures 0.33 ± 0.06
All heavy atoms in secondary structures 0.83 ± 0.11
Ramachandran statistics (%)
Residues in most favored regions 81.1
Residues in additional allowed regions 17.9
Residues in generously allowed regions 0.4
Residues in disallowed regions 0.7
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change experiments were performed on Bruker Avance 600 MHz
spectrometer at 298 K. The chemical shifts were referenced to
internal 2,2-dimethyl-2-silapentanesulfonic acid (DSS) [16]. All
NMR spectra were processed using NMRPipe [17] and analyzed
using NMRView [18].
2.3. Structure calculations
Distance restraints for structure calculation were generated by
using the three-dimensional 15N-edited, 13C-edited aliphatic andFig. 1. Solution structure of H-REV107 N. (A and C) Superimposition of the backbone tra
Ribbon diagrams of the mean structure with the secondary structural elements labeled13C-edited aromatic NOESY-HSQC spectra. Dihedral angle re-
straints were determined from backbone chemical shifts using TA-
LOS [19]. Hydrogen bond restraints were obtained based on data
from the hydrogen–deuterium exchange experiments. The tauto-
meric states of all four histidine residues were determined from
2D 1H to 15N HMQC spectrum (Supplementary Fig. 1) [20]. The
structure calculations were performed using CYANA [21]. A total
of 200 structures were calculated using CYANA, and 100 structures
with the lowest target function values were selected. Then the
structure reﬁnement was carried out using the generalized Born
(GB) solvent model in AMBER [22–23]. Finally, the 20 lowest en-
ergy structures were selected for representation. The ﬁnal struc-
tures were analyzed using PROCHECK_NMR [24] and MOLMOL
[25].3. Results
3.1. Solution structure of H-REV107 N-terminal domain
The N-terminal phospholipase domain of H-REV107 (residues
1–125, H-REV107N) was expressed in Escherichia coli as a water
soluble and well folded protein. The solution structure of H-
REV107N was determined with high quality with 3486 inter-pro-
ton NOE-derived distance constraints together with 74 dihedral
angle and 26 hydrogen bond constraints. The constraints and
structural statistics are summarized in Table 1. The 20 representa-
tive structures of H-REV107N have been deposited under PDB ID:
2KYT.
The structure of H-REV107N comprises a six-stranded anti-par-
allel b-sheet (b1, residues 13–18; b2, residues 21–29; b3, residues
32–37; b4, residues 58–64; b5, residues 73–76; b6, residues 103–
104) and three a helices (a1, residues 65–68; a2, residues 89–
99; a3, residues 110–122) with a b1–b2–b3–b4–a1–b5–a2–b6–
a3 sequential connectivity (Fig. 1). The short helix a1 is on one side
of the b-sheet, while helices a2 and a3 are on the other side. Thece of the 20 representative structures of H-REV107 N with a 65 rotation. (B and D)
oriented as (A and C), respectively.
Fig. 2. Structural comparison of H-REV107 N and the NlpC/P60 domain of Spr (PDB: 2K1G). A, primary sequence alignment of H-REV107 N and the NlpC/P60 domain of Spr
from E. coli performed by ClustalX [33] and pictured by ESPript 2.2 (http://espript.ibcp.fr/ESPript/ESPript/). The secondary structural elements are labeled, and the individual
secondary elements in the two proteins are labeled in different colors (H-REV107 in red, and Spr in blue). The residue numbers are respectively labeled on different side of the
sequences. The three residues of the Cys-His-His catalytic triad are indicated by blue triangles. B, structural comparison of H-REV107 N (pink) and the NlpC/P60 domain of Spr
(PDB: 2K1G) (pale blue) in ribbon diagram (27). The two swapped a-helices are highlighted in red for H-REV107 N and in blue for Spr. C and D, topologies of H-REV107 N and
2K1G with the sequence number labeled. The colors of the two swapped a-helices and the ﬁve b-strands are corresponding to those in B.
Fig. 3. The catalytic triads of H-REV107 N and the NlpC/P60 domain of Spr (PDB:
2K1G). The side chain heavy atoms of the Cys-His-His catalytic triad residues in
each structure are shown in different colors (H-REV107 in red and 2K1G in blue).
The distances between C113 Sc and H23 Nd1 atoms and between H23 Ne2 and
H35 Nd1 atoms from the mean structure of H-REV107N are indicated in red, and the
corresponding distances (C68 Sc to H119 Nd1, and H119 Ne2 to H131 Nd1) from the
mean structure of 2K1G are indicated in blue. The conserved arginine residue of H-
REV107 near the catalytic triad is shown in red.
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connecting strand b3 and b4 are very ﬂexible.
3.2. Structural comparison of H-REV107N and classical NlpC/P60
domain
As H-REV107 was proposed to be a circular permutation with
the catalytic domain of classical NlpC/P60 family proteins, we com-
pared the structure of H-REV107N with that of the NlpC/P60 pep-
tidase domain of E. coli lipoprotein Spr (PDB: 2K1G) [14,26].
Indeed, the overall architectures of the two structures are quite
similar, even though their topologies are different (Fig. 2). Super-
imposing the ﬁve b-strands b1–b5 in H-REV107N with the corre-
sponding b-strands in Spr reveals a backbone heavy atom root
mean square deviation (RMSD) of 1.8 Å for the ﬁve b-strands, while
the backbone heavy atom RMSD of helices a2 and a3 in H-REV107
and the corresponding a-helices in Spr is 4.0 Å (Fig. 2B). The major
difference between the two structures is that helices a2 and a3 in
H-REV107N are located at the C-terminus of the polypeptides, but
the two structurally corresponding a-helices in Spr are at the N-
terminus of the NlpC/P60 peptidase domain, which is typical of cir-
cular permutation (Fig. 2A). The structure of H-REV107N provides a
direct evidence for the existence of circular permutation in NlpC/
P60 domain proteins.
4. Discussion
In this paper, we report the solution structure of the N-terminal
phospholipase domain of H-REV107, the ﬁrst structure of the novel
H-REV107-like tumor suppressor family, which provides the struc-
tural evidence for the circular permutation of NlpC/P60 domain
proteins.
In previous reports, residues H23 and C113 of H-REV107 were
found to be essential for its phospholipase activity [11–13]. Struc-tural comparison also reveals that residues C113, H23 and H35 of
H-REV107 are located at almost identical positions as residues
C68, H119 and H131 that form a Cys–His–His catalytic triad in
the NlpC/P60 peptidase domain of Spr [26]. Side-chains of these
corresponding residues also point in similar directions, respec-
tively (Fig. 3). The two histidine residues in the catalytic triad are
in the neutral Ne2–H tautomeric state, the same as in the structure
Fig. 4. Sequence alignments of the catalytic domains of H-REV107 and LRAT family proteins HRASL2, TIG3 and LRAT generated by ClustalX [33] and pictured by ESPript 2.2
(http://espript.ibcp.fr/ESPript/ESPript/). The secondary structural elements of H-REV107N are labeled. The residue numbers of H-REV107 are labeled on the top. The three
residues of Cys-His-His catalytic triad and the conserved arginine residues are indicated by blue triangles.
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strates, H-REV107 should adopt a similar catalytic mechanism as
that of the NlpC/P60 peptidase domain of Spr, in which the depro-
tonation of the residue C113 thiol by the basic side-chain of resi-
due H23 generates a nucleophile anionic sulfur to attack the
carbonyl group of the substrate, and the third polar residue H35 as-
sists to properly orient the side-chain of H23 [14,26].
H-REV107-like family proteins also belong to the lecithin reti-
nol acyltransferase (LRAT) protein family, which are essential en-
zymes in the all-trans-retinol metabolism. Except for the
predicted N- and C-terminal transmembrane domain of LRAT
[27], the catalytic domains of H-REV107 and LRAT are highly
homologous (identity 26%) [28,29] (Fig. 4). The structure of H-
REV107N is also the ﬁrst structure of LRAT family, which may pro-
vide structural insight for understanding the mechanism of LRAT. It
was reported that C161 and H60 are essential for the activity of
LRAT and formed catalytic dyad through the sequence alignments
and mutagenesis [28]. However, in the thiol enzymes, a third polar
residue that is also important for the catalysis is still not clearly
identiﬁed even though extensive mutagenesis studies have been
carried out [28–30]. Based on the primary sequence alignments
and the structure of H-REV107N (Fig. 4), we propose that the con-
served residues C161, H60, and H72 of LRAT should form a Cys–
His–His catalytic triad as that in H-REV107, and H72 should corre-
spond to H35 of H-REV107 and play the role to position the side-
chain of H60. It has been reported that the H72Q mutant of LRAT
is a little more active than wild-type LRAT [30], suggesting that
glutamine can play a similar role as histidine at this position
[26,31]. In addition, the positively charged residue R18 of H-
REV107 is just located near the catalytic triad and it is highly con-
served in the LRAT family, which may play a role in stabilizing the
phosphate group of the phospholipid substrates as the arginine
residue in cytosolic phospholipase A2 does [32] (Fig. 3).
In summary, we have solved the solution structure of the N-ter-
minal catalytic domain of H-REV107, which is the ﬁrst structure of
H-REV107-like family, and also the ﬁrst structure of circular per-
mutated NlpC/P60 domains. According to the structural analysis,
the phospholipase active site of H-REV107 consists a Cys–His–His
catalytic triad, indicating H-REV107 should adopt a similar cata-
lytic mechanism as NlpC/P60 peptidases, which also provides
structural insights for the lecithin retinol acyltransferase.
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